Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masatake Tanaka

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Canadian Journal of Gastroenterology & Hepatology|March 8, 2021
Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular CarcinomaHideo Suzuki, Motoyuki Kohjima, Masatake Tanaka, et al.
Cell Reports|May 20, 2023
FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidationShun Fujinuma, Hirokazu Nakatsumi, Hideyuki Shimizu, et al.
Journal of Inflammation (London, England)|June 21, 2024
Microcirculatory disturbance in acute liver injury is triggered by IFNγ-CD40 axisMiho Kurokawa, Takeshi Goya, Motoyuki Kohjima, et al.
International Journal of Molecular Medicine|November 4, 2009
Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?Makoto Nakamuta, Ryoko Yada, Tatsuya Fujino, et al.
Journal of Gastroenterology and Hepatology|August 9, 2025
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal ImpairmentEiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, et al.
Journal of Gastroenterology and Hepatology|February 3, 2025
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting AntiviralsEiichi Ogawa, Akira Kawano, Motoyuki Kohjima, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2023
Bone marrow-derived fibroblast migration via periostin causes irreversible arthrogenic contracture after joint immobilizationHirotaka Iura, Kazu Kobayakawa, Hirokazu Saiwai, et al.
Medicine|October 12, 2022
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational studyRie Sugimoto, Takeaki Satoh, Akihiro Ueda, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2022
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular CarcinomaRie Sugimoto, Kenta Motomura, Aritsune Ooho, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Canadian Journal of Gastroenterology & Hepatology|March 8, 2021
Metabolic Alteration in Hepatocellular Carcinoma: Mechanism of Lipid Accumulation in Well-Differentiated Hepatocellular CarcinomaHideo Suzuki, Motoyuki Kohjima, Masatake Tanaka, et al.
Cell Reports|May 20, 2023
FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidationShun Fujinuma, Hirokazu Nakatsumi, Hideyuki Shimizu, et al.
Journal of Inflammation (London, England)|June 21, 2024
Microcirculatory disturbance in acute liver injury is triggered by IFNγ-CD40 axisMiho Kurokawa, Takeshi Goya, Motoyuki Kohjima, et al.
International Journal of Molecular Medicine|November 4, 2009
Changes in the expression of cholesterol metabolism-associated genes in HCV-infected liver: a novel target for therapy?Makoto Nakamuta, Ryoko Yada, Tatsuya Fujino, et al.
Journal of Gastroenterology and Hepatology|August 9, 2025
Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal ImpairmentEiichi Ogawa, Motoyuki Kohjima, Toshimasa Koyanagi, et al.
Journal of Gastroenterology and Hepatology|February 3, 2025
Long-Term Liver Morbidity and Mortality After Hepatitis C Virus Elimination by Direct-Acting AntiviralsEiichi Ogawa, Akira Kawano, Motoyuki Kohjima, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 31, 2023
Bone marrow-derived fibroblast migration via periostin causes irreversible arthrogenic contracture after joint immobilizationHirotaka Iura, Kazu Kobayakawa, Hirokazu Saiwai, et al.
Medicine|October 12, 2022
Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational studyRie Sugimoto, Takeaki Satoh, Akihiro Ueda, et al.
Internal Medicine (Tokyo, Japan)|November 3, 2022
Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular CarcinomaRie Sugimoto, Kenta Motomura, Aritsune Ooho, et al.
Pageof 5